TK
Insider
Tasos Konidaris
Executive Vice President & CFOTasos Konidaris (Executive Vice President & CFO) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $4.7M of AMRX (499,730 sh across 3 lots, as filed), executed Aug 13 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.6M
shares × price, as filed
Last traded
Aug 15 2025
Filed Aug 15 2025
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 2 sells
2 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$4.7M499,730 sh across 3 lots
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $891K
100,000 sh × $8.91
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET